Feasibility of diagnosing subclinical renal allograft rejection in children by whole blood gene expression analysis

Transplantation

Volumn 86, Issue 9, 2008, Pages 1222-1228

  Alakulppi, Noora ^a   Seikku, Paula ^b   Jaatinen, Taina ^a   Holmberg, Christer ^b   Laine, Jarmo ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Microarray; Pediatric kidney transplantation; Subclinical rejection

Indexed keywords

AZATHIOPRINE; CD40 LIGAND; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; BIOLOGICAL MARKER; INDUCIBLE T CELL CO STIMULATOR; INDUCIBLE T-CELL CO-STIMULATOR; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; INDUCIBLE T CELL COSTIMULATOR GENE; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; MICROARRAY ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; ALLOTRANSPLANTATION; BIOPSY; BLOOD; DNA MICROARRAY; GENETICS; GRAFT REJECTION; INFANT; KIDNEY; METABOLISM; PATHOLOGY;

ADOLESCENT; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; BIOPSY; CD40 LIGAND; CHILD; CHILD, PRESCHOOL; FEASIBILITY STUDIES; FEMALE; GRAFT REJECTION; HUMANS; INFANT; KIDNEY; KIDNEY TRANSPLANTATION; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 58149156584     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181883fb0     Document Type: Article

References (26)

1. Birk PE, Stannard KM, Konrad HB, et al. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children. Pediatr Transplant 2004; 8: 29.
2. Seikku P, Krogerus L, Jalanko H, et al. Better renal function with enhanced immunosuppression and protocol biopsies after kidney transplantation in children. Pediatr Transplant 2005; 9: 754.
3. Ibernon M, Goma M, Moreso F, et al. Subclinical rejection impairs glomerular adaptation after renal transplantation. Kidney Int 2006; 70: 557.
4. Birk PE, Blydt-Hansen TD, Dart AB, et al. Low incidence of adverse events in outpatient pediatric renal allograft biopsies. Pediatr Transplant 2007; 11: 196.
5. Nankivell BJ, Chapman JR. The significanceofsubclinical rejection and the value of protocol biopsies. Am J Transplant 2006; 6: 2006.
6. Lachenbruch PA, Rosenberg AS, Bonvini E, et al. Biomarkers and surrogate endpoints in renal transplantation: Present status and considerations for clinical trial design. Am J Transplant 2004; 4: 451.
7. Bradley BA. Prognostic assays for rejection and tolerance in organ transplantation. Transpl Immunol 2005; 14: 193.
8. Alakulppi NS, Kyllönen LE, Partanen J, et al. Diagnosis of acute renal allograft rejection by analyzing whole blood mRNA expression of lymphocyte marker molecules. Transplantation 2007; 83: 791.
9. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
10. Rush D. Insights into subclinical rejection. Transplant Proc 2004; 36: 71S.
11. Stordeur P, Zhou L, Byl B, et al. Immune monitoring in whole blood using real-time PCR. J Immunol Methods 2003; 276: 69.
12. Thach DC, Lin B, Walter E, et al. Assessment of two methods for handling blood in collection tubes with RNA stabilizing agent for surveillance of gene expression profiles with high density microarrays. J Immunol Methods 2003; 283: 269.
13. Rainen L, Oelmueller U, Jurgensen S, et al. Stabilization of mRNA expression in whole blood samples. Clin Chem 2002; 48: 1883.
14. Feezor RJ, Baker HV, Mindrinos M, et al. Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 2004; 19: 247.
15. McLean A. What goes around (in kidney transplant rejection) does not necessarily come around (in the blood). Am J Transplant 2003; 3: 1045.
16. Hoffmann SC, Hale DA, Kleiner DE, et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005; 5: 573.
17. Alvarez CM, Paris SC, Arango L, et al. Kidney transplant patients with long-term graft survival have altered expression of molecules associated with T-cell activation. Transplantation 2004; 78: 1541.
18. Muthukumar T,DadhaniaD, Ding R,et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353: 2342.
19. Liu J, Walter E, Stenger D, et al. Effects of globin mRNA reduction methods on gene expression profiles from whole blood. J Mol Diagn 2006; 8: 551.
20. Chua MS, BarryC,ChenX,etal. Molecular profilingof anemiain acute renal allograft rejection using DNA microarrays. Am J Transplant 2003; 3: 17.
21. Horwitz PA, Tsai EJ, Putt ME, et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 2004; 110: 3815.
22. Akalin E, Hendrix RC, Polavarapu RG, et al. Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology. Transplantation 2001; 72: 948.
23. Flechner SM, Kurian SM, Head SR, et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004; 4: 1475.
24. Mansfield ES, Sarwal MM. Arraying the orchestration of allograft pathology. Am J Transplant 2004; 4: 853.
25. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125.
26. Kestilä M, Lenkkeri U, Männikkö M, et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital ne-phrotic syndrome. Mol Cell 1998; 1: 575.